AP3179A - Benzofuranyl derivatives used as glucokinase inhibitors - Google Patents

Benzofuranyl derivatives used as glucokinase inhibitors

Info

Publication number: AP3179A
Authority: AP; ARIPO
Prior art keywords: derivatives used; glucokinase inhibitors; benzofuranyl derivatives; benzofuranyl; glucokinase
Prior art date: 2009-03-11

Application number

AP2011005882A

Other languages

English (en)

Other versions

AP2011005882A0 (en

Inventor

Jeffrey Allen Pfeferkorn

Anthony Lai Ling

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-11

Filing date

2010-03-04

Publication date

2015-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42124287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3179(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-03-04 Application filed by Pfizer filed Critical Pfizer

2011-10-31 Publication of AP2011005882A0 publication Critical patent/AP2011005882A0/xx

2015-03-31 Application granted granted Critical

2015-03-31 Publication of AP3179A publication Critical patent/AP3179A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AP2011005882A 2009-03-11 2010-03-04 Benzofuranyl derivatives used as glucokinase inhibitors AP3179A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15909909P	2009-03-11	2009-03-11
PCT/IB2010/050943 WO2010103437A1 (en)	2009-03-11	2010-03-04	Benzofuranyl derivatives used as glucokinase inhibitors

Publications (2)

Publication Number	Publication Date
AP2011005882A0 AP2011005882A0 (en)	2011-10-31
AP3179A true AP3179A (en)	2015-03-31

Family

ID=42124287

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2011005882A AP3179A (en)	2009-03-11	2010-03-04	Benzofuranyl derivatives used as glucokinase inhibitors

Country Status (37)

Country	Link
US (2)	US8455496B2 (ru)
EP (2)	EP2604604A1 (ru)
JP (1)	JP5086480B2 (ru)
KR (1)	KR101295937B1 (ru)
CN (1)	CN102388038B (ru)
AP (1)	AP3179A (ru)
AR (1)	AR075729A1 (ru)
AU (1)	AU2010222589B2 (ru)
BR (1)	BRPI1013246B1 (ru)
CA (1)	CA2754681C (ru)
CL (1)	CL2011002185A1 (ru)
CO (1)	CO6430427A2 (ru)
CR (1)	CR20110467A (ru)
CU (1)	CU24036B1 (ru)
DK (1)	DK2406253T3 (ru)
DO (1)	DOP2011000279A (ru)
EA (1)	EA018894B1 (ru)
EC (1)	ECSP11011306A (ru)
ES (1)	ES2427279T3 (ru)
GE (1)	GEP20156239B (ru)
HR (1)	HRP20130661T1 (ru)
IL (1)	IL214942A (ru)
MA (1)	MA33119B1 (ru)
MY (1)	MY151246A (ru)
NI (1)	NI201100166A (ru)
NZ (1)	NZ595024A (ru)
PE (1)	PE20120668A1 (ru)
PL (1)	PL2406253T3 (ru)
PT (1)	PT2406253E (ru)
RS (1)	RS52903B (ru)
SI (1)	SI2406253T1 (ru)
TN (1)	TN2011000454A1 (ru)
TW (1)	TWI383981B (ru)
UA (1)	UA99882C2 (ru)
UY (1)	UY32480A (ru)
WO (1)	WO2010103437A1 (ru)
ZA (1)	ZA201106632B (ru)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2547679T1 (sl)	2010-03-19	2015-12-31	Pfizer Inc.	Derivati 2,3 dihidro-1H-inden-1-il-2,7-diazaspiro(3.6)nonana in njihova uporaba kot antagonisti ali inverzni agonisti grelinskega receptorja
HUE025078T2 (en)	2010-10-29	2016-01-28	Pfizer	N1 / N2-lactam-acetyl-CoA carboxylase inhibitors
MX348860B (es)	2011-04-22	2017-06-30	Pfizer	Derivados de pirazoloespirocetona para usarse como inhibidores de acetil-coa carboxilasa.
CA2841757A1 (en)	2011-07-15	2013-01-24	Etzer Darout	Gpr 119 modulators
BR112014000288A2 (pt)	2011-07-22	2017-01-10	Pfizer	moduladores do receptor de glucagon de quinolinila
WO2013030713A1 (en)	2011-08-31	2013-03-07	Pfizer Inc.	Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
CN103917529B (zh)	2011-11-11	2016-08-17	辉瑞大药厂	2-硫代嘧啶酮类
AP2014007953A0 (en)	2012-04-06	2014-09-30	Pfizer	Diacylglycerol acyltransferase 2 inhibitors
US8889730B2 (en)	2012-04-10	2014-11-18	Pfizer Inc.	Indole and indazole compounds that activate AMPK
WO2013164730A1 (en)	2012-05-04	2013-11-07	Pfizer Inc.	Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
EP2897964A1 (en)	2012-09-20	2015-07-29	Pfizer Inc.	Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
CA2893256A1 (en)	2012-12-11	2014-06-19	Pfizer Inc.	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
JP6162820B2 (ja)	2012-12-19	2017-07-12	ファイザー・インク	炭素環式および複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
WO2014125394A1 (en)	2013-02-13	2014-08-21	Pfizer Inc.	HETEROARYL-SUBSTITUTED HEXAHYDROPYRANO [3,4-d][1,3] THIAZIN-2-AMINE COMPOUNDS
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
JP6348582B2 (ja)	2013-10-09	2018-06-27	ファイザー・インク	プロスタグランジンｅｐ３受容体の拮抗薬
SI3119757T1 (en)	2014-03-17	2018-08-31	Pfizer Inc.	Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders
RS58597B1 (sr)	2014-04-04	2019-05-31	Pfizer	Biciklično-spojena heteroaril ili aril jedinjenja i njihova upotreba kao irak4 inhibitora
CN106459088A (zh)	2014-04-10	2017-02-22	辉瑞公司	2‑氨基‑6‑甲基‑4，4a，5，6‑四氢吡喃并[3，4‑d][1，3]噻嗪‑8a(8H)‑基‑1，3‑噻唑‑4‑基酰胺
CN104387348A (zh) *	2014-10-27	2015-03-04	湖南华腾制药有限公司	一种苯并呋喃衍生物的制备方法
WO2016092413A1 (en)	2014-12-10	2016-06-16	Pfizer Inc.	Indole and indazole compounds that activate ampk
JP2017538769A (ja)	2014-12-22	2017-12-28	ファイザー・インク	プロスタグランジンｅｐ３受容体の拮抗薬
DK3265126T3 (da)	2015-03-03	2021-09-13	Saniona As	Kombinationsformulering af tesofensin og metoprolol
MA42035A (fr)	2015-05-05	2018-03-14	Pfizer	2-thiopyrimidinones
CA2987179C (en)	2015-05-29	2020-08-25	Pfizer Inc.	Heterocyclic compounds as inhibitors of vanin-1 enzyme
PL3310784T3 (pl)	2015-06-17	2021-03-08	Pfizer Inc.	Związki tricykliczne i ich zastosowanie jako inhibitory fosfodiesterazy
WO2016203335A1 (en)	2015-06-18	2016-12-22	Pfizer Inc.	Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
JP2018527337A (ja)	2015-08-13	2018-09-20	ファイザー・インク	二環式縮合ヘテロアリールまたはアリール化合物
ES2865199T3 (es)	2015-08-27	2021-10-15	Pfizer	Compuestos de heteroarilo o arilo condensados bicíclicos como moduladores de IRAK4
WO2017037567A1 (en)	2015-09-03	2017-03-09	Pfizer Inc.	Regulators of frataxin
WO2017051294A1 (en)	2015-09-24	2017-03-30	Pfizer Inc.	N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
JP2018531924A (ja)	2015-09-24	2018-11-01	ファイザー・インク	テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
BR112018003489A2 (pt)	2015-09-24	2018-09-25	Pfizer	n-[2-(2-amino-6,6-dissubstituído-4,4a,5,6-tetra-hidropirano[3,4-d][1,3]tiazin-8a(8h)-il)-1,3-tiazol-4-il]amidas
DK3397631T3 (da)	2015-12-29	2021-05-25	Pfizer	Substituerede 3-azabicyclo[3.1.0]hexaner som ketohexokinase-inhibitorer
AU2017296338A1 (en)	2016-07-14	2019-01-03	Pfizer Inc.	Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
AR109179A1 (es)	2016-08-19	2018-11-07	Pfizer	Inhibidores de diacilglicerol aciltransferasa 2
GB201714777D0 (en)	2017-09-14	2017-11-01	Univ London Queen Mary	Agent
WO2019133445A1 (en)	2017-12-28	2019-07-04	Inception Ibd, Inc.	Aminothiazoles as inhibitors of vanin-1
US11992477B2 (en) *	2018-05-31	2024-05-28	Hua Medicine (Shanghai) Ltd.	Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof
US11254660B2 (en)	2018-08-31	2022-02-22	Pfizer Inc.	Combinations for treatment of NASH/NAFLD and related diseases
US20210338776A1 (en) *	2018-09-06	2021-11-04	Yale University	Treatments against mosquito-borne viruses based on mosquito salivary gland proteins
WO2020102575A1 (en)	2018-11-16	2020-05-22	Inception Ibd, Inc.	Heterocyclic aminothiazoles and uses thereof
EP3972596B1 (en)	2019-05-20	2025-07-16	Pfizer Inc.	Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
WO2020261144A1 (en)	2019-06-28	2020-12-30	Pfizer Inc.	5-(thiophen-2-yl)-1h-tetrazole derivatives as bckdk inhibitors useful for treating various diseases
TW202115086A (zh)	2019-06-28	2021-04-16	美商輝瑞大藥廠	Bckdk抑制劑
TWI771766B (zh)	2019-10-04	2022-07-21	美商輝瑞股份有限公司	二醯基甘油醯基轉移酶２抑制劑
WO2021155841A1 (en)	2020-02-07	2021-08-12	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
JP2022058085A (ja)	2020-02-24	2022-04-11	ファイザー・インク	ジアシルグリセロールアシルトランスフェラーゼ２阻害剤とアセチル－ＣｏＡカルボキシラーゼ阻害剤との組合せ
FI4161927T3 (fi)	2020-06-09	2024-10-03	Pfizer	Spiroyhdisteitä melanokortiini-4-reseptorin antagonisteina ja niiden käyttöjä
WO2023026180A1 (en)	2021-08-26	2023-03-02	Pfizer Inc.	Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3- yl)pyrimidine-5-carboxamide
JP7704982B2 (ja)	2021-12-01	2025-07-08	ファイザー・インク	糖尿病、腎疾患、ｎａｓｈおよび心不全を処置するための分枝鎖アルファケト酸デヒドロゲナーゼキナーゼ阻害剤としての３－フェニル－１－ベンゾチオフェン－２－カルボン酸誘導体
ES3039638T3 (en)	2021-12-06	2025-10-23	Pfizer	Melanocortin 4 receptor antagonists and uses thereof
EP4490155A1 (en)	2022-03-09	2025-01-15	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
EP4508047A1 (en)	2022-04-14	2025-02-19	Gasherbrum Bio, Inc.	Heterocyclic glp-1 agonists
WO2024075051A1 (en)	2022-10-07	2024-04-11	Pfizer Inc.	Hsd17b13 inhibitors and/or degraders
EP4605076A1 (en)	2022-10-18	2025-08-27	Pfizer Inc.	Patatin-like phospholipase domain-containing protein 3 (pnpla3) modifiers
WO2024118524A1 (en)	2022-11-28	2024-06-06	Cerevel Therapeutics, Llc	Azaindole compounds and their use as phosphodiesterase inhibitors
EP4634180A1 (en)	2022-12-15	2025-10-22	Gasherbrum Bio, Inc.	Salts and solid forms of a compound having glp-1 agonist activity
CN120731201A (zh)	2022-12-16	2025-09-30	辉瑞公司	含3-氟-4-羟基苯甲酰胺的抑制剂和/或降解剂及其用途
AU2024250528A1 (en)	2023-04-14	2025-10-23	Pfizer Inc.	Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof
WO2025099566A1 (en)	2023-11-08	2025-05-15	Pfizer Inc.	A crystalline form of 6-fluoro-3-(2,4,5-trifluoro-3-methoxyphenyl)-1-benzothiophene-2-carboxylic acid
TW202539633A (zh)	2024-02-01	2025-10-16	美商輝瑞股份有限公司	葡萄糖依賴性促胰島素多肽受體拮抗劑及其用途
WO2025224599A1 (en)	2024-04-22	2025-10-30	Pfizer Inc.	Pyrrolidine-based glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof
WO2026013531A1 (en)	2024-07-10	2026-01-15	Pfizer Inc.	Spiro[2.5]octane compounds

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5795984A (en) *	1980-12-05	1982-06-15	Tanabe Seiyaku Co Ltd	Pyridinecarboxamide derivative and its preparation
US5399564A (en)	1991-09-03	1995-03-21	Dowelanco	N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
WO1994001415A1 (fr)	1992-07-03	1994-01-20	Kumiai Chemical Industry Co., Ltd.	Derive heterocyclique condense et desherbant
KR100381584B1 (ko) *	1994-07-22	2003-08-21	알타나 파마 아게	디히드로벤조푸란
DE4434637A1 (de)	1994-09-28	1996-04-04	Hoechst Schering Agrevo Gmbh	Substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
WO1996011920A1 (en) *	1994-10-13	1996-04-25	Pfizer Inc.	Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
CA2202056A1 (en) *	1994-10-13	1996-04-25	Mark A. Dombroski	Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
DE19603576A1 (de)	1996-02-01	1997-08-07	Bayer Ag	Acylierte 4-Amino und 4-Hydrazinopyrimidine
CN1219171A (zh) *	1996-05-20	1999-06-09	达尔文发现有限公司	苯并呋喃甲酰胺及其治疗用途
AU4454597A (en) *	1996-08-19	1998-03-06	Byk Gulden Lomberg Chemische Fabrik Gmbh	Novel benzofuran-4-carboxamides
WO1999040085A1 (en) *	1998-02-09	1999-08-12	Darwin Discovery Limited	Benzofuran-4-carboxamides and their therapeutic use
PL350050A1 (en) *	1999-01-22	2002-10-21	Elan Pharm Inc	Acyl derivatives which treat vla-4 related disorders
SE9901573D0 (sv)	1999-05-03	1999-05-03	Astra Ab	New compounds
WO2002020463A2 (en)	2000-09-05	2002-03-14	Tularik Inc.	Fxr modulators
WO2002040448A1 (en)	2000-11-20	2002-05-23	Bristol-Myers Squibb Company	Pyridone derivatives as ap2 inhibitors
ATE316965T1 (de)	2000-12-06	2006-02-15	Hoffmann La Roche	Kondensierte heteroaromatische glucokinaseaktivatoren
WO2002051836A1 (en)	2000-12-27	2002-07-04	Kyowa Hakko Kogyo Co., Ltd.	Dipeptidyl peptidase iv inhibitor
CA2439152C (en)	2001-02-28	2008-06-17	Merck & Co., Inc.	Acylated piperidine derivatives as melanocortin-4 receptor agonists
US7199147B2 (en) *	2001-06-12	2007-04-03	Dainippon Sumitomo Pharma Co., Ltd.	Rho kinase inhibitors
SE0102300D0 (sv) *	2001-06-26	2001-06-26	Astrazeneca Ab	Compounds
MXPA04003758A (es)	2001-10-22	2005-06-20	Univ New York State Res Found	Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
JP4164031B2 (ja)	2002-02-14	2008-10-08	ファルマシアコーポレーション	Ｐ３８ｍａｐキナーゼのモジュレータとしての置換されたピリジノン
CN100357283C (zh) *	2002-04-02	2007-12-26	中国科学院上海药物研究所	一类甲硫氨酰氨肽酶抑制剂
WO2003092670A1 (en)	2002-05-03	2003-11-13	Warner-Lambert Company Llc	Bombesin antagonists
EP1511733A2 (en)	2002-06-13	2005-03-09	E.I. Du Pont De Nemours And Company	Pyrazole and pyrrole carboxamide insecticides
JP4302967B2 (ja) *	2002-11-18	2009-07-29	パイオニア株式会社	楽曲検索方法、楽曲検索装置及び楽曲検索プログラム
GB0226930D0 (en)	2002-11-19	2002-12-24	Astrazeneca Ab	Chemical compounds
EP1433778A1 (en)	2002-12-23	2004-06-30	Jerini AG	Use of nitriles as rotamase inhibitors
EP1594863A1 (en)	2003-02-11	2005-11-16	Prosidion Limited	Tri(cyclo) substituted amide glucokinase activator compounds
AR045414A1 (es) *	2003-02-13	2005-10-26	Banyu Pharma Co Ltd	Derivados de 2 - piridincarboxamida y composiciones farmaceuticas que las contienen.
CN100378094C (zh) *	2003-02-13	2008-04-02	万有制药株式会社	2-吡啶甲酰胺衍生物
CL2004000303A1 (es)	2003-02-20	2005-04-08	Tibotec Pharm Ltd	Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
NZ541824A (en) *	2003-02-26	2010-04-30	Banyu Pharma Co Ltd	Heteroarylcarbamoylbenzene derivatives as glucokinase activators
US20060205751A1 (en) *	2003-07-15	2006-09-14	Smithkline Beecham Corporation	Novel compounds
EP1653944B1 (en) *	2003-08-01	2010-11-10	Chugai Seiyaku Kabushiki Kaisha	Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
CL2004002050A1 (es)	2003-08-13	2005-06-03	Pharmacia Corp Sa Organizada B	Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
EP1532980A1 (en)	2003-11-24	2005-05-25	Novo Nordisk A/S	N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
SE0303480D0 (sv) *	2003-12-19	2003-12-19	Biovitrum Ab	Benzofuranes
BRPI0509573A (pt)	2004-04-02	2007-09-25	Novartis Ag	derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
BRPI0510273A (pt)	2004-05-25	2007-10-30	Pfizer Prod Inc	derivados de tetraazabenzo[e]azuleno e análogos destes
JP4719745B2 (ja)	2004-07-29	2011-07-06	メルク・シャープ・エンド・ドーム・コーポレイション	カリウムチャンネル阻害剤
EP1786783A1 (en)	2004-09-01	2007-05-23	Rigel Pharmaceuticals, Inc.	Synthesis of 2,4-pyrimidinediamine compounds
GB0420719D0 (en)	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
SE0403006D0 (sv) *	2004-12-09	2004-12-09	Biovitrum Ab	New compounds
KR20070088798A (ko) *	2004-12-21	2007-08-29	에프. 호프만-라 로슈 아게	크로만 유도체 및 그의 5-ｈｔ 수용체 리간드로서의 용도
JP4167218B2 (ja)	2004-12-22	2008-10-15	株式会社メタル建材	薄板用タッピンねじ
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
TW200700392A (en)	2005-03-16	2007-01-01	Astrazeneca Ab	Novel compounds
BRPI0608659A2 (pt)	2005-04-06	2010-11-30	Astrazeneca Ab	composto, métodos para limitar a proliferação celular, de tratamento de um ser humano ou animal sofrendo de uma doença, e de tratamento de profilaxia do cáncer, para tratar cáncer, de tratamento de infecções associadas com cáncer, e de profilaxia de infecções associadas com cáncer, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, métodos para inibir chk1 cinase, e um pak cinase, e para limitar a tumorigênese em um ser humano ou animal, e, processo para a preparação de um composto ou um sal farmaceuticamente aceitável do mesmo
US7754717B2 (en)	2005-08-15	2010-07-13	Amgen Inc.	Bis-aryl amide compounds and methods of use
RU2008112184A (ru)	2005-08-31	2009-10-10	Астеллас Фарма Инк. (Jp)	Производное тиазола
JP2009013065A (ja) *	2005-10-14	2009-01-22	Astellas Pharma Inc	縮合へテロ環化合物
US20090215801A9 (en)	2005-11-15	2009-08-27	Astrazeneca Ab, Sodertaije, Swedenastex Thereapeutics Ltd	Novel 2-Aminopyrimidinone Derivatives And Their Use
US8034822B2 (en) *	2006-03-08	2011-10-11	Takeda San Diego, Inc.	Glucokinase activators
EP1999135A2 (en)	2006-03-30	2008-12-10	Takeda San Diego, Inc.	Kinase inhibitors
NL2000581C2 (nl) *	2006-04-20	2008-01-03	Pfizer Prod Inc	Aangecondenseerde fenylamidoheterocyclische verbindingen.
US7842713B2 (en) *	2006-04-20	2010-11-30	Pfizer Inc	Fused phenyl amido heterocyclic compounds
JP5419706B2 (ja)	2006-12-20	2014-02-19	タケダカリフォルニアインコーポレイテッド	グルコキナーゼアクチベーター
JP2010138073A (ja)	2007-03-30	2010-06-24	Taisho Pharmaceutical Co Ltd	ピコリン酸アミド化合物
US8299115B2 (en)	2007-06-08	2012-10-30	Debnath Bhuniya	Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
WO2010084428A1 (en) *	2009-01-20	2010-07-29	Pfizer Inc.	Substituted pyrazinone amides

2010
- 2010-03-04 UA UAA201110834A patent/UA99882C2/ru unknown
- 2010-03-04 SI SI201030278T patent/SI2406253T1/sl unknown
- 2010-03-04 PE PE2011001580A patent/PE20120668A1/es not_active Application Discontinuation
- 2010-03-04 EP EP13158856.8A patent/EP2604604A1/en not_active Withdrawn
- 2010-03-04 PL PL10708644T patent/PL2406253T3/pl unknown
- 2010-03-04 EA EA201190158A patent/EA018894B1/ru not_active IP Right Cessation
- 2010-03-04 AP AP2011005882A patent/AP3179A/xx active
- 2010-03-04 EP EP10708644.9A patent/EP2406253B1/en active Active
- 2010-03-04 ES ES10708644T patent/ES2427279T3/es active Active
- 2010-03-04 DK DK10708644.9T patent/DK2406253T3/da active
- 2010-03-04 MA MA34164A patent/MA33119B1/fr unknown
- 2010-03-04 AU AU2010222589A patent/AU2010222589B2/en not_active Ceased
- 2010-03-04 CA CA2754681A patent/CA2754681C/en not_active Expired - Fee Related
- 2010-03-04 RS RS20130355A patent/RS52903B/sr unknown
- 2010-03-04 BR BRPI1013246-5A patent/BRPI1013246B1/pt not_active IP Right Cessation
- 2010-03-04 JP JP2011553571A patent/JP5086480B2/ja not_active Expired - Fee Related
- 2010-03-04 WO PCT/IB2010/050943 patent/WO2010103437A1/en not_active Ceased
- 2010-03-04 CN CN201080016137.6A patent/CN102388038B/zh active Active
- 2010-03-04 HR HRP20130661AT patent/HRP20130661T1/hr unknown
- 2010-03-04 MY MYPI2011004231 patent/MY151246A/en unknown
- 2010-03-04 PT PT107086449T patent/PT2406253E/pt unknown
- 2010-03-04 KR KR1020117023630A patent/KR101295937B1/ko not_active Expired - Fee Related
- 2010-03-04 GE GEAP201313280A patent/GEP20156239B/en unknown
- 2010-03-04 NZ NZ595024A patent/NZ595024A/xx not_active IP Right Cessation
- 2010-03-09 UY UY0001032480A patent/UY32480A/es not_active Application Discontinuation
- 2010-03-10 TW TW099106974A patent/TWI383981B/zh active
- 2010-03-10 AR ARP100100715A patent/AR075729A1/es unknown
- 2010-03-10 US US12/720,724 patent/US8455496B2/en active Active
2011
- 2011-08-31 CR CR20110467A patent/CR20110467A/es unknown
- 2011-09-01 IL IL214942A patent/IL214942A/en active IP Right Grant
- 2011-09-02 NI NI201100166A patent/NI201100166A/es unknown
- 2011-09-02 CU CU2011000168A patent/CU24036B1/es active IP Right Grant
- 2011-09-05 CL CL2011002185A patent/CL2011002185A1/es unknown
- 2011-09-06 EC EC2011011306A patent/ECSP11011306A/es unknown
- 2011-09-08 DO DO2011000279A patent/DOP2011000279A/es unknown
- 2011-09-08 TN TN2011000454A patent/TN2011000454A1/fr unknown
- 2011-09-09 ZA ZA2011/06632A patent/ZA201106632B/en unknown
- 2011-09-12 CO CO11117871A patent/CO6430427A2/es active IP Right Grant
2013
- 2013-05-22 US US13/899,851 patent/US8735396B2/en active Active

Also Published As

Publication number	Publication date
DK2406253T3 (da)	2013-08-12
PE20120668A1 (es)	2012-06-01
RS52903B (sr)	2014-02-28
EP2604604A1 (en)	2013-06-19
AP2011005882A0 (en)	2011-10-31
BRPI1013246A2 (pt)	2016-04-05
CA2754681C (en)	2014-01-07
GEP20156239B (en)	2015-01-26
JP2012520286A (ja)	2012-09-06
HRP20130661T1 (en)	2013-08-31
JP5086480B2 (ja)	2012-11-28
BRPI1013246B1 (pt)	2019-10-01
ECSP11011306A (es)	2011-10-31
IL214942A0 (en)	2011-11-30
US20100234285A1 (en)	2010-09-16
ES2427279T3 (es)	2013-10-29
TW201036961A (en)	2010-10-16
SI2406253T1 (sl)	2013-09-30
MY151246A (en)	2014-04-30
TWI383981B (zh)	2013-02-01
CN102388038B (zh)	2014-04-23
US8735396B2 (en)	2014-05-27
AU2010222589B2 (en)	2012-08-16
EA201190158A1 (ru)	2012-04-30
CU20110168A7 (es)	2012-02-15
UA99882C2 (ru)	2012-10-10
NZ595024A (en)	2013-01-25
WO2010103437A1 (en)	2010-09-16
UY32480A (es)	2010-10-29
CU24036B1 (es)	2014-10-30
NI201100166A (es)	2012-01-23
DOP2011000279A (es)	2011-10-15
EA018894B1 (ru)	2013-11-29
PT2406253E (pt)	2013-09-11
KR20110123288A (ko)	2011-11-14
US20130252973A1 (en)	2013-09-26
IL214942A (en)	2015-10-29
TN2011000454A1 (fr)	2013-03-27
US8455496B2 (en)	2013-06-04
CN102388038A (zh)	2012-03-21
CR20110467A (es)	2011-10-07
CL2011002185A1 (es)	2012-02-03
CO6430427A2 (es)	2012-04-30
HK1164281A1 (en)	2012-09-21
AU2010222589A1 (en)	2011-09-22
AR075729A1 (es)	2011-04-20
KR101295937B1 (ko)	2013-08-14
MA33119B1 (fr)	2012-03-01
PL2406253T3 (pl)	2013-10-31
CA2754681A1 (en)	2010-09-16
EP2406253B1 (en)	2013-07-03
EP2406253A1 (en)	2012-01-18
ZA201106632B (en)	2012-05-30

Publication	Publication Date	Title
AP3179A (en)	2015-03-31	Benzofuranyl derivatives used as glucokinase inhibitors
ZA201204246B (en)	2013-09-25	Kinase inhibitors
ZA201203842B (en)	2013-01-30	Kinase inhibitors
IL220212A0 (en)	2012-07-31	Aminopyrimidine kinase inhibitors
PL2454250T3 (pl)	2015-08-31	Inhibitory kinazy regulującej sygnał apoptozy
IL216742A0 (en)	2012-03-01	Bace inhibitors
IL219087A0 (en)	2012-06-28	Benzimidazole-imidazole derivatives
IL217956A0 (en)	2012-03-29	N1-sulfonyl-5-fluoropyrimidinone derivatives
IL217953A0 (en)	2012-03-29	5-fluoropyrimidinone derivatives
ZA201201295B (en)	2012-10-31	Substituted xanthine derivatives
EP2396004A4 (en)	2012-07-25	SELECTIVE KINASE HEMMER
IL216007A0 (en)	2012-01-31	Isoxazole-pyridine derivatives
IL215109A0 (en)	2011-12-29	Isoxazole-pyridazine derivatives
IL214941A0 (en)	2011-11-30	Isoxazole-pyrazole derivatives
IL217952A0 (en)	2012-03-29	N1-acyl-5-fluoropyrimidinone derivatives
IL213927A0 (en)	2011-07-31	Deoxyactagardine derivatives
EP2473052A4 (en)	2013-03-20	SUBSTITUTED XANTHINE DERIVATIVES
IL216761A0 (en)	2012-02-29	Pyrazinooxazepine derivatives
IL213935A0 (en)	2011-07-31	Novel heterocyclic compounds as metap-2 inhibitors
GB0914726D0 (en)	2009-09-30	Kinase inhibitors
IL213262A0 (en)	2011-07-31	Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en)	2009-08-26	Indopyl-pyridone derivatives
GB0903650D0 (en)	2009-04-15	Glyoalase inhibitors
GB0902661D0 (en)	2009-04-01	Inhibitors